Baidu
map
AM J CLIN ONCOL-CANC 润色咨询

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

出版年份:1982 年文章数:1946 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2014-11-24 xyj2014

    我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2020-02-24 1891e9713cm

    想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-11-14 ms3000001388865590

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-05-19 oncology2005

    偏重的研究方向:肿瘤临床
    经验分享:一周后,变为with editor,希望别被拒。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2019-01-24 亮亮1954

    这本 杂志接收Meta分析吗,有经验的战友分享下经验。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-10-20 阿雨菇凉

    偏重的研究方向:肿瘤;SEER
    经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2012-06-28 匿名用户

    不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2014-07-31 citron521

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。
    特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。
    只要文章质量入了编辑法眼,很快接受。。。
    再改点语法,但是正式上线出版至少得等一年。。。

    总结:接受/拒绝快,正式刊出慢

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    引言和讨论如何写的不重复?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了,但正式出版期卷页码还没出来,怎么这么慢啊?那如果是2015年才出版,那出版年份是不是就算2015年的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=521, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬,今天投了一篇文章,状态是submitted to journal,然后view QC results里面的figures出现AQC Error,其他都是N/A状态,是怎么回事?需要处理吗?文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:不知道为什么他家的网站总是进不去,莫名其妙就是服务器超时,有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向:肿瘤临床<br>经验分享:一周后,变为with editor,希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本 杂志接收Meta分析吗,有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向:肿瘤;SEER<br>经验分享:10.4 帮师姐投了一篇生信,10.8拒搞,推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投,特别是偏基础的文章,投了2篇均被拒,但是拒稿很快(7-10天),基础研究最好不要尝试(个人意见)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=589, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:这个杂志偏重临床,基础试验的同学们就尽量避免吧。 <br> 特别喜欢接受临床实验的文章,但是设计要合理,对样本量分析等有要求。。。 <br> 只要文章质量入了编辑法眼,很快接受。。。 <br> 再改点语法,但是正式上线出版至少得等一年。。。 <br> <br> 总结:接受/拒绝快,正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比,引言撰写的方式有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 小动量

    和讨论比,引言撰写的方式有什么不同?

    1

    展开1条回复
共54条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map